Evidence map›Paper›PMID 36914835›Full record

ArticleNature genetics2023

Multiancestry genomic and transcriptomic analysis of gastric cancer.

Yasushi Totoki, Mihoko Saito-Adachi, Yuichi Shiraishi, Daisuke Komura, Hiromi Nakamura, Akihiro Suzuki, Kenji Tatsuno, Hirofumi Rokutan, Natsuko Hama, Shogo Yamamoto and 31 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. MicroRNA-597 Suppresses Gastric Cancer Invasion and Progression viaInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. [Next-Generation Sequencing-Based Detection of Gene Mutations and Its Association With Clinicopathological Features in Gastric Cancer].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Clinicopathological and genomic features of extrachromosomal DNA in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 9 institutions in 3 countries.

Yasushi TotokiDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1876-6859
Mihoko Saito-AdachiDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9213-0184
Yuichi ShiraishiDivision of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6144-5845
Daisuke KomuraDepartment of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0038-728X
Hiromi NakamuraDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Akihiro SuzukiDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Kenji TatsunoGenome Science and Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3046-3941
Hirofumi RokutanDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4172-4892
Natsuko HamaDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Shogo YamamotoGenome Science and Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5564-2567
Hanako OnoDivision of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.
Yasuhito AraiDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6306-9409
Fumie HosodaDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Hiroto KatohDepartment of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9440-728X
Kenichi ChibaDivision of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
Naoko IidaDivision of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
Genta NagaeGenome Science and Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2929-7990
Hiroki UedaBiological Data Science, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Chen ShihangGenome Science and Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Shigeki SekineDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
Hiroyuki AbeDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4513-1007
Sachiyo NomuraDepartment of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4293-6205
Tetsuya MatsuuraDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Eiji SakaiDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Takashi OhshimaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
Yasushi RinoDepartment of Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Khay Guan YeohDept of Medicine, National University of Singapore, Singapore, Singapore.
Jimmy SoDept of Surgery, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-9772-7905
Kaushal SanghviDept of Surgery, Tan Tock Seng Hospital, Singapore, Singapore.
Richie SoongCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-0152-1225
Akihiko FukagawaDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Shinichi YachidaDepartment of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.ORCID http://orcid.org/0000-0001-5507-4566
Mamoru KatoDivision of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8485-8316
Yasuyuki SetoDepartment of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-1763-8380
Atsushi NakajimaDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.ORCID http://orcid.org/0000-0002-6263-1436
Hitoshi KataiDepartment of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
Patrick TanCancer and Stem Cell Biology, Duke-NUS Medical School Singapore, Singapore, Singapore.
Shumpei IshikawaDepartment of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki AburataniGenome Science and Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0438-1544
Tatsuhiro ShibataDivision of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan. tshibata@ims.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-0477-210X
The University of Tokyo · JPYokohama City University · JPNational University of Singapore · SGTokyo National Hospital · JPDuke-NUS Medical School · SGKanagawa Prefectural Hospital Organization · JPNational Cancer Research Institute · GBTan Tock Seng Hospital · SGThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is among the most common malignancies worldwide, characterized by geographical, epidemiological and histological heterogeneity. Here, we report an extensive, multiancestral landscape of driver events in gastric cancer, involving 1,335 cases. Seventy-seven significantly mutated genes (SMGs) were identified, including ARHGAP5 and TRIM49C. We also identified subtype-specific drivers, including PIGR and SOX9, which were enriched in the diffuse subtype of the disease. SMGs also varied according to Epstein-Barr virus infection status and ancestry. Non-protein-truncating CDH1 mutations, which are characterized by in-frame splicing alterations, targeted localized extracellular domains and uniquely occurred in sporadic diffuse-type cases. In patients with gastric cancer with East Asian ancestry, our data suggested a link between alcohol consumption or metabolism and the development of RHOA mutations. Moreover, mutations with potential roles in immune evasion were identified. Overall, these data provide comprehensive insights into the molecular landscape of gastric cancer across various subtypes and ancestries.

Indexed as

Epstein-Barr Virus InfectionsStomach NeoplasmsGenomicsHerpesvirus 4, HumanHumansTranscriptome

Identifiers

PMID36914835
OpenAlexW4324129066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.